Today: 9 April 2026
Browse Category

NASDAQ:MRNA 28 September 2025 - 6 November 2025

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

U.S. stocks opened lower Thursday as investors weighed weak private jobs data and mixed earnings. Challenger reported over 150,000 announced layoffs in October, the highest for the month in more than 20 years. The dollar fell for a second day as traders raised odds of a December Fed rate cut. Qualcomm and DoorDash dropped on company risks; Datadog and Moderna gained on strong results.
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna reported Q3 2025 revenue of $1.02 billion and a GAAP loss of $0.51 per share, both ahead of analyst forecasts, driven by $971 million in COVID-19 vaccine sales. The company narrowed its full-year revenue outlook to $1.6–$2.0 billion, cut operating-expense guidance by $700 million, and raised its year-end cash target. Shares rose pre-market but traded unevenly during the session.
Nasdaq Rally Amid Tech Frenzy: Markets Brush Off Shutdown Fears in Late September 2025

U.S. Stock Market Today (Nov. 6, 2025): Futures Mixed as Jobless Claims & Productivity Loom; Tesla Pay Vote, Airbnb & DraftKings Earnings in Focus

U.S. equity futures edged lower early Thursday as Asian markets rebounded on strong U.S. data, while European shares slipped. Treasury yields rose and the dollar stayed firm. Key U.S. data releases include jobless claims and productivity at 8:30 a.m. ET. Qualcomm, Arm, and Snap moved pre-market on earnings, with several major reports due before and after the bell.
Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Moderna shares surged 12% to near $27.50 on Oct. 30, 2025, after reports of takeover talks with a large drugmaker. The rally follows a STAT News report on possible deals, but Moderna declined comment. Despite gains, the stock remains down about 37% year-to-date. Recent FDA approvals include updated COVID and RSV vaccines, but falling COVID demand has cut 2025 revenue and forced cost reductions.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 19.10.2025

China blocked Ant Group and JD.com from launching stablecoins, reinforcing state control over digital currency. U.S. stock futures rose ahead of a packed earnings week, with Tesla and Netflix among companies reporting. IonQ reported Q3 revenue up 102% to $12.4 million but posted a $52.5 million net loss, while Nvidia posted record Q3 revenue of $35.1 billion.
Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna shares rose 5% to $28 but remain down 35% in 2024 and nearly 80% below last year’s level. COVID vaccine sales have collapsed from $18.9 billion in 2022 to $3.1 billion, and Q2 revenue fell 41% to $142 million. The company cut its 2025 revenue forecast and is laying off 10% of staff. Early data from an experimental cancer vaccine showed a 24% tumor response rate in advanced melanoma.
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna closed at $27.34 on Oct 7, 2025, with a market cap near $11 billion. Q2 revenue fell 41% year-over-year to $142 million, and the company posted a net loss of $0.8 billion. U.S. and EU regulators limited updated COVID booster use, narrowing near-term revenue prospects. Analysts’ 12-month price targets remain high, but sales forecasts have repeatedly missed expectations.
Billion-Dollar AI Bets and Biotech Breakthroughs: Top Tech News (Sept 27–28, 2025)

Billion-Dollar AI Bets and Biotech Breakthroughs: Top Tech News (Sept 27–28, 2025)

Nvidia will invest up to $100 billion to build 10 gigawatts of AI data centers for OpenAI, with the first 1 GW due by late 2026. The US cybersecurity agency issued an emergency directive after hackers breached at least one federal agency via Cisco firewall flaws, affecting hundreds of devices. The FDA approved Eli Lilly’s new breast cancer drug Inluriyo. The SEC loosened ETF rules, opening the door for new crypto ETFs.

Stock Market Today

  • Sensex Drops Nearly 800 Points as Oil Prices Rebound and Iran-US Ceasefire Concerns Return
    April 9, 2026, 1:04 AM EDT. The BSE Sensex slumped 794.65 points (1.02%) to 76,768.25, while the Nifty 50 fell 196.55 points (0.82%) to 23,800.80 on Thursday. Gains from the previous session's relief rally, sparked by a temporary Iran-US ceasefire and falling crude oil prices, reversed sharply. The rebound in crude oil prices renewed inflation fears, pressured the rupee and corporate margins, dampening investor sentiment. Analysts noted the ceasefire remains fragile and the market's recovery vulnerable if oil prices spike again. Heavyweight stocks including HDFC Bank, Infosys, and Reliance Industries dragged the indices down. The decline underscores continued volatility driven by geopolitical risks and oil price fluctuations, with markets reacting to headlines rather than fundamentals.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 1:05 AM EDT Rolls-Royce Holdings Stock Valuation After 95% Annual Gain: Overvalued or Opportunity? April 9, 2026, 1:05 AM EDT. Rolls-Royce Holdings (LSE:RR.) has surged 95% over the past year, reaching around £12.78 per share. Despite recent momentum with a 5.9% weekly and 6.8% year-to-date rise, valuation metrics suggest caution. A Discounted Cash Flow (DCF) analysis estimates intrinsic value at roughly £9.03, indicating the stock may be overvalued by approximately 41.5%. Meanwhile, the Price-to-Earnings (P/E) ratio for Rolls-Royce stands at 18.1x, below the Aerospace & Defense sector average
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Go toTop